Tags:BioTechDiagnosticsHealthPersonalProduct
Asuragen leverages RNA expertise to focus on emerging opportunities in personalized medicine for cancer patients, creating novel diagnostic products that facilitate early diagnosis and treatment outcome. Acquired by Bio-Techne in 2021.
Likes
115
Location: United States, Austin
Phone: Array

Investors 1

Mentions in press and media 3

DateTitleDescriptionCategoryAuthorSource
10.12.2014Three new ...Three new biomarker companies ...--cambridgen...
03.04.2008Life-scien...TODAY’S HEADLINES: Mirna The...--venturebea...
10.12.2007Life scien...TODAY’S HEADLINES: Fundamen...--venturebea...